HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuko Muto Selected Research

7- amino- 2- (((2- methyl- 1- (3- phenylpropanoylamino)propyl)hydroxyphosphinoyl)methyl)heptanoic acid

5/2009EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats.
1/2007EF6265, a novel plasma carboxypeptidase B inhibitor, protects against renal dysfunction in rat thrombotic glomerulonephritis through enhancing fibrinolysis.
5/2004Enhancement of fibrinolysis by EF6265 [(S)-7-amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuko Muto Research Topics

Disease

2Infections
06/2022 - 03/2008
1Anemia
06/2022
1Hemolytic Anemia
06/2022
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
06/2022
1COVID-19
06/2022
1Cough
06/2022
1Dyspnea (Shortness of Breath)
06/2022
1Monoclonal Gammopathy of Undetermined Significance
06/2022
1Endotoxemia
05/2009
1Sepsis (Septicemia)
05/2009
1Pancreatitis
03/2008
1Atherosclerosis
03/2007
1Glomerulonephritis
01/2007
1Edema (Dropsy)
01/2007
1Thrombosis (Thrombus)
05/2004

Drug/Important Bio-Agent (IBA)

37- amino- 2- (((2- methyl- 1- (3- phenylpropanoylamino)propyl)hydroxyphosphinoyl)methyl)heptanoic acidIBA
05/2009 - 05/2004
2Anti-Bacterial Agents (Antibiotics)IBA
05/2009 - 03/2008
1Hemoglobins (Hemoglobin)IBA
06/2022
1Immunoglobulin M (IgM)IBA
06/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022
1AgglutininsIBA
06/2022
1LipopolysaccharidesIBA
05/2009
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
05/2009
1Ceftazidime (Fortum)FDA LinkGeneric
05/2009
1FibrinIBA
05/2009
1Fibrinogen (Factor I)FDA Link
05/2009
1biapenem (L 627)IBA
03/2008
1Taurocholic Acid (Sodium Taurocholate)IBA
03/2008
1ImipenemFDA Link
03/2008
1Carbapenems (Carbapenem Antibiotics)IBA
03/2008
1PolyphenolsIBA
03/2007
1Proanthocyanidins (Procyanidins)IBA
03/2007
1oxidized low density lipoproteinIBA
03/2007
1Urea (Carbamide)FDA LinkGeneric
01/2007
1NitrogenIBA
01/2007
1Carboxypeptidase BIBA
01/2007
1AcidsIBA
05/2004
1Phosphinic Acids (Phosphinic Acid)IBA
05/2004

Therapy/Procedure

1Therapeutics
06/2022
1Intravenous Injections
05/2009